From: The impact of carotid plaque presence and morphology on mortality outcome in cardiological patients
Ā | All (n = 541) | Absence of plaque (n = 180) | Presence of plaque (n = 361) | p |
---|---|---|---|---|
Age, y | 66 Ā± 10.9 | 61.7 Ā± 12.6 | 68.7 Ā± 9.2 | <0.001 |
Males | 411 (76%) | 134 (74.4%) | 277 (76.7%) | 0.59 |
Diabetes | 112 (20.7%) | 28 (15.6%) | 84 (23.3%) | 0.04 |
Hypertension | 290 (53.6%) | 77 (42.8%) | 213 (59%) | <0.001 |
Hypercholesterolemia | 310 (57%) | 111 (61%) | 199 (55%) | 0.16 |
Hypertrigliceridemia | 131 (24.2%) | 49 (27.2%) | 82 (22.7%) | 0.28 |
Obesity | 135 (25%) | 47 (26.1%) | 88 (24.4%) | 0.67 |
Angina at admission | 338 (62.5%) | 101 (56.1%) | 237 (65.7%) | 0.03 |
Ejection fraction <50% | 141(26.1%) | 35 (19.4%) | 106 (29.4%) | 0.01 |
Treatment | Ā | Ā | Ā | Ā |
Statins | 163 (30%) | 49 (27%) | 114 (31%) | 0.31 |
Beta-blockers | 157 (29%) | 48 (26%) | 109 (30 %) | 0.42 |
Antiplatelet-agents | 376 (70%) | 113 (62 %) | 263 (73%) | 0.018 |
ACE inhibitors | 133 (25%) | 32 (17%) | 101 (28%) | 0.011 |
Nitrate | 323 (60%) | 88 (48%) | 235 (65%) | 0.000 |